Medical Devices Startups
6,320 companies tagged Medical Devices, with their investors and founders.
Merit Medical Systems designs, develops, manufactures and markets medical devices for interventional and diagnostic procedures. The company serves healthcare providers and clinical practitioners in the medical device industry.
2 investors
Metaphore develops a platform that measures biological activity inside cells at scale to design antibody medicines with novel mechanisms of action. The company aims to create antibodies that activate pathways, modulate signaling, and engage multiple targets to treat complex diseases.
2 investors
Methinks develops artificial intelligence software modules that detect acute stroke conditions (large vessel occlusions and intracranial hemorrhages) from medical imaging scans for hospital stroke teams. The products are integrated within Microsoft Teams to streamline clinical workflow and patient care coordination.
2 investors
Metrion Biosciences provides ion channel screening and drug discovery services for pharmaceutical and biotech companies. The company specializes in preclinical contract research operations with over 100 years of combined team expertise in ion channel biology.
2 investors
Micro Interventional Devices designs and manufactures medical devices for transcatheter cardiac repair procedures, enabling minimally invasive alternatives to open-heart surgery. The company initially focuses on transcatheter mitral and tricuspid valve repair solutions.
2 investors
Microbiotica is a clinical-stage biopharmaceutical company developing precision live biotherapeutic products derived from the human microbiome for immuno-oncology and inflammatory bowel disease. The company uses a proprietary microbiome profiling platform based on clinical data to identify specific bacterial strains associated with patient benefit.
2 investors
MicroCare formulates specialized cleaning, coating, and lubricating fluids for electronics manufacturing, medical device production, fiber optic installation, aerospace and defense, semiconductor fabrication, and healthcare facilities. The company serves industrial and healthcare sectors requiring high-purity contamination removal and has operated globally since 1983.
2 investors
Micron Biomedical develops dissolvable microarray technology for vaccine and therapeutic delivery as an alternative to traditional injections, targeting expanded global access to treatments across all age groups. The company operates at the clinical stage and is building manufacturing capacity for needle-free pharmaceuticals.
2 investors
Microsure develops a microsurgical robot that enables surgeons to perform operations on sub-millimeter anatomical structures with enhanced precision and comfort. The company aims to increase access to microsurgery by allowing specialists to work more effectively and treating more patients in need.
2 investors
Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved treatment for stroke survivors with moderate to severe upper extremity impairment. The company delivers clinically validated recovery solutions specifically for chronic ischemic stroke patients.
2 investors
miDiagnostics develops a portfolio of molecular diagnostic tests designed for rapid and accurate results to support healthcare professionals in clinical diagnosis and patient care.
2 investors
Milliin (θΏζ·©) develops hemodialysis equipment and related products, including dialysis machines, dialysis water treatment systems, centralized concentrate supply systems, and dialysis dry powder. Its products serve medical and clinical dialysis settings.
2 investors
Mimetas provides microfluidic technology and services for 3D tissue culture research, offering pre-built tissue models, instrumentation, and platforms for pharmaceutical and safety testing applications.
2 investors
MIMOSA Diagnostics develops medical devices and technology to improve healthcare equity through diagnostic solutions. The company focuses on skin and wound healing diagnostics with a team led by experienced medical device engineers and healthcare professionals.
2 investors
Mindera Health develops digital predictive skin analytics technology, described as Dermal Intelligence, aimed at improving health economic outcomes in dermatology. The company operates in the digital health and diagnostics space.
2 investors
MindMaze develops neurotherapeutic solutions combining behavioral therapy, software, devices, and data to treat and manage neurological disease and support brain health and recovery. Its precision neurotherapeutic products are used by patients and caregivers in clinical centers worldwide.
2 investors
Mindpeak develops AI-powered diagnostic software for cancer pathology, translating complex tissue data into clinical insights to support treatment decisions. The company serves pathologists and clinical institutions working in cancer diagnostics and drug development.
2 investors
Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients. The company focuses on cardiac disease medical technology aimed at improving outcomes and preventing heart failure.
2 investors
Mirati develops investigational medicines and treatments for patients with multiple myeloma and other oncology indications. The company's focus is on advancing novel therapeutic approaches in oncology.
2 investors
mjn develops neurological monitoring technology solutions for patients with epilepsy and other neurological disorders. The company's mjn-VISOR system enables ambulatory monitoring of brain activity.
2 investors
Model N provides software for end-to-end commercialization, revenue optimization, and regulatory compliance aimed at pharmaceutical and medtech companies.
2 investors
Modulari-T develops proprietary cell therapy technologies, including the MARC receptor and MoVe platform, based on primary research into immune system architecture. The company serves the cell therapy and immunotherapy market.
2 investors
Modulim develops spatial frequency domain imaging (SFDI) technology that provides clinicians with microvascular and tissue oxygenation insights for the lower limb, supporting assessment of conditions such as diabetic circulatory complications. The company builds point-of-care medical imaging devices for healthcare providers.
2 investors
Mogassam Co. develops automatic DLP 3D printers and dental CAM software for dental professionals including dentists and dental technicians to produce 3D-printed dental work.
2 investors